United States Biotechnology & Medical Research

Maze Therapeutics, Inc. (MAZE)

Track

Track

Maze Therapeutics experienced significant selling activity recently, with executives offloading over 1.1 million dollars in stock. Forty-seven transactions occurred, all being disposals. This trend follows a 11.9% decline in share value over ninety days. No purchases were recorded, and the next earnings report is scheduled for November 2026.
Ticker: MAZE Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Maze Therapeutics, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Bernstein Harold President, R&D & CMO Officer
Transaction date
Planned sale
Price
89.04
Quantity 30,905 +46.9%
Value US$1,693,060
HAROLD BERNSTEIN Officer Officer
Transaction date
Proposed sale
Price
263.77
Quantity 17,871
Value US$3,481,758
4.0
Courtney Phillips GC and Corp. Secretary Officer
Transaction date
Sale
Price
314.66
Quantity 28,480 +10.7%
Value US$3,782,884
4.0
Courtney Phillips GC and Corp. Secretary Officer
Transaction date
Sale
Price
26.01
Quantity 1,000 -22.1%
Value US$100,000
Coloma Jason V Chief Executive Officer Executive Director
Transaction date
Sale
Price
25.77
Quantity 1,000 -0.5%
Value US$100,000
Coloma Jason V Chief Executive Officer Executive Director
Transaction date
Sale
Price
26.01
Quantity 1,000 -29.1%
Value US$100,000
Bernstein Harold President, R&D & CMO Officer
Transaction date
Sale
Price
25.78
Quantity 1,000 -0.6%
Value US$100,000
Bernstein Harold President, R&D & CMO Officer
Transaction date
Sale
Price
26.01
Quantity 1,000 -34.4%
Value US$100,000
Dandekar Atul CSBO Officer
Transaction date
Sale
Price
25.81
Quantity 1,000 -0.1%
Value US$100,000
Dandekar Atul CSBO Officer
Transaction date
Sale
Price
26.01
Quantity 1,000 -9.0%
Value US$100,000
4.0
Courtney Phillips GC and Corp. Secretary Officer
Transaction date
Sale
Price
27.12
Quantity 1,000 -2.6%
Value US$100,000
4.0
Courtney Phillips GC and Corp. Secretary Officer
Transaction date
Sale
Price
26.38
Quantity 1,000 -15.8%
Value US$100,000
Coloma Jason V Chief Executive Officer Executive Director
Transaction date
Sale
Price
27.12
Quantity 1,000 -3.4%
Value US$100,000
Coloma Jason V Chief Executive Officer Executive Director
Transaction date
Sale
Price
26.38
Quantity 1,000 -19.7%
Value US$100,000
Bernstein Harold President, R&D & CMO Officer
Transaction date
Sale
Price
27.12
Quantity 1,000 -4.0%
Value US$100,000
Bernstein Harold President, R&D & CMO Officer
Transaction date
Sale
Price
26.38
Quantity 1,000 -22.4%
Value US$100,000
Dandekar Atul CSBO Officer
Transaction date
Sale
Price
27.12
Quantity 1,000 -1.1%
Value US$100,000
Dandekar Atul CSBO Officer
Transaction date
Sale
Price
26.38
Quantity 1,000 -7.2%
Value US$100,000
Atul Dandekar Officer Officer
Transaction date
Proposed sale
Price
26.53
Quantity 6,679
Value US$177,200
Jason V Coloma Officer Officer
Transaction date
Proposed sale
Price
26.53
Quantity 23,497
Value US$623,400
4.0
Courtney Phillips Officer Officer
Transaction date
Proposed sale
Price
26.54
Quantity 4,144
Value US$110,000
Harold Bernstein Officer Officer
Transaction date
Proposed sale
Price
26.53
Quantity 10,685
Value US$283,500
Bernstein Harold President, R&D & CMO Officer
Transaction date
Planned sale
Price
26.36
Quantity 16,141 -100.0%
Value US$425,512
Coloma Jason V Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
26.29
Quantity 31,908 -12.5%
Value US$838,785
Coloma Jason V Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
26.31
Quantity 2,593 -12.5%
Value US$68,214
Coloma Jason V Officer Officer
Transaction date
Proposed sale
Price
26.32
Quantity 34,501
Value US$908,066
Dandekar Atul CSBO Officer
Transaction date
Planned sale
Price
27.58
Quantity 7,500 -22.2%
Value US$206,824
Bernstein Harold President, R&D & CMO Officer
Transaction date
Planned sale
Price
27.61
Quantity 16,142 -100.0%
Value US$445,621
Coloma Jason V Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
27.09
Quantity 1,604 -0.6%
Value US$43,445
Coloma Jason V Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
26.71
Quantity 30,304 -10.6%
Value US$809,541
Coloma Jason V Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
27.09
Quantity 154 -0.7%
Value US$4,172
Coloma Jason V Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
26.71
Quantity 2,439 -10.5%
Value US$65,157
Coloma Jason V Officer Officer
Transaction date
Proposed sale
Price
26.74
Quantity 34,501
Value US$922,557
Dandekar Atul CSBO Officer
Transaction date
Planned sale
Price
27.89
Quantity 400 -1.5%
Value US$11,156
Dandekar Atul CSBO Officer
Transaction date
Planned sale
Price
27.31
Quantity 7,100 -21.0%
Value US$193,875
ATUL DANDEKAR Officer Officer
Transaction date
Proposed sale
Price
27.88
Quantity 22,500
Value US$627,300
Bernstein Harold President, R&D & CMO Officer
Transaction date
Planned sale
Price
30.34
Quantity 1,200 -100.0%
Value US$36,404
Bernstein Harold President, R&D & CMO Officer
Transaction date
Planned sale
Price
29.87
Quantity 13,409 -91.8%
Value US$400,460
Coloma Jason V Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
30.44
Quantity 1,597 -0.6%
Value US$48,606
Coloma Jason V Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
29.95
Quantity 30,311 -9.5%
Value US$907,921
Coloma Jason V Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
29.98
Quantity 2,593 -10.0%
Value US$77,726
HAROLD BERNSTEIN Officer Officer
Transaction date
Proposed sale
Price
29.84
Quantity 46,892
Value US$1,399,257
Coloma Jason V Officer Officer
Transaction date
Proposed sale
Price
29.98
Quantity 34,501
Value US$1,034,254
Dandekar Atul CSBO Officer
Transaction date
Planned sale
Price
28.02
Quantity 7,500 -22.2%
Value US$210,150
Coloma Jason V Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
26.05
Quantity 23,865 -7.0%
Value US$621,674
Coloma Jason V Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
26.00
Quantity 2,040 -7.3%
Value US$53,040
Coloma Jason V Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
26.00
Quantity 1,953 -0.6%
Value US$50,781
Bernstein Harold President, R&D & CMO Officer
Transaction date
Planned sale
Price
26.36
Quantity 1,600 -100.0%
Value US$42,172
Bernstein Harold President, R&D & CMO Officer
Transaction date
Planned sale
Price
25.57
Quantity 13,253 -89.2%
Value US$338,940
Coloma Jason V Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
26.24
Quantity 553 -1.9%
Value US$14,511
Coloma Jason V Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
26.20
Quantity 6,090 -1.7%
Value US$159,537
Coloma Jason V Officer Officer
Transaction date
Proposed sale
Price
26.32
Quantity 34,501
Value US$908,066
Dandekar Atul CSBO Officer
Transaction date
Planned sale
Price
26.34
Quantity 7,500 -23.2%
Value US$197,554
Coloma Jason V Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
26.02
Quantity 25,582 -6.8%
Value US$665,516
Coloma Jason V Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
26.00
Quantity 2,478 -8.0%
Value US$64,428
Coloma Jason V Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
26.00
Quantity 4,504 -1.2%
Value US$117,104
Coloma Jason V Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
26.00
Quantity 116 -0.4%
Value US$3,016
Coloma Jason V Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
26.00
Quantity 1,822 -0.5%
Value US$47,372
Coloma Jason V Officer Officer
Transaction date
Proposed sale
Price
25.95
Quantity 34,502
Value US$895,327
Bernstein Harold President, R&D & CMO Officer
Transaction date
Planned sale
Price
26.22
Quantity 15,000 -100.0%
Value US$393,354
Dandekar Atul CSBO Officer
Transaction date
Planned sale
Price
25.37
Quantity 7,500 -41.7%
Value US$190,299
Bachrodt Amy SVP, Finance Officer
Transaction date
Planned sale
Price
30.34
Quantity 300 -2.3%
Value US$9,101
Bachrodt Amy SVP, Finance Officer
Transaction date
Planned sale
Price
30.34
Quantity 300 -2.3%
Value US$9,101
Bachrodt Amy SVP, Finance Officer
Transaction date
Planned sale
Price
29.32
Quantity 2,200 -14.2%
Value US$64,510
Bachrodt Amy SVP, Finance Officer
Transaction date
Planned sale
Price
29.32
Quantity 2,200 -14.2%
Value US$64,510
Bernstein Harold President, R&D & CMO Officer
Transaction date
Planned sale
Price
31.07
Quantity 300 -100.0%
Value US$9,320
Bernstein Harold President, R&D & CMO Officer
Transaction date
Planned sale
Price
30.06
Quantity 3,348 -91.8%
Value US$100,636
Bernstein Harold President, R&D & CMO Officer
Transaction date
Planned sale
Price
29.24
Quantity 11,352 -75.7%
Value US$331,948
Dandekar Atul CSBO Officer
Transaction date
Planned sale
Price
30.02
Quantity 790 -7.0%
Value US$23,714
Dandekar Atul CSBO Officer
Transaction date
Planned sale
Price
29.26
Quantity 6,710 -37.3%
Value US$196,305
ATUL DANDEKAR Officer Officer
Transaction date
Proposed sale
Price
30.38
Quantity 30,000
Value US$911,400
Bernstein Harold President, R&D & CMO Officer
Transaction date
Planned sale
Price
50.02
Quantity 5,044 -100.0%
Value US$252,294
Bernstein Harold President, R&D & CMO Officer
Transaction date
Planned sale
Price
49.32
Quantity 3,795 -42.9%
Value US$187,169
Bernstein Harold President, R&D & CMO Officer
Transaction date
Planned sale
Price
48.20
Quantity 6,161 -41.1%
Value US$296,977
Bernstein Harold President, R&D & CMO Officer
Transaction date
Planned sale
Price
51.02
Quantity 348 -100.0%
Value US$17,753
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-08 2026-09-04 PlS Planned sale
Bernstein Harold

President, R&D & CMO

Officer
30,905 +46.9%
89.04
US$1,693,060 		30,905 +46.9% 89.04 US$1,693,060
2026-09-04 2026-09-04 PrS Proposed sale
HAROLD BERNSTEIN

Officer

Officer
17,871
263.77
US$3,481,758 		17,871 263.77 US$3,481,758
2026-09-04 2026-09-03 S Sale
4.0
Courtney Phillips

GC and Corp. Secretary

Officer
28,480 +10.7%
314.66
US$3,782,884 		28,480 +10.7% 314.66 US$3,782,884
2026-09-04 2026-09-03 S Sale
4.0
Courtney Phillips

GC and Corp. Secretary

Officer
1,000 -22.1%
26.01
US$100,000 		1,000 -22.1% 26.01 US$100,000
2026-09-04 2026-09-03 S Sale
Coloma Jason V

Chief Executive Officer

Executive Director
1,000 -0.5%
25.77
US$100,000 		1,000 -0.5% 25.77 US$100,000
2026-09-04 2026-09-03 S Sale
Coloma Jason V

Chief Executive Officer

Executive Director
1,000 -29.1%
26.01
US$100,000 		1,000 -29.1% 26.01 US$100,000
2026-09-04 2026-09-03 S Sale
Bernstein Harold

President, R&D & CMO

Officer
1,000 -0.6%
25.78
US$100,000 		1,000 -0.6% 25.78 US$100,000
2026-09-04 2026-09-03 S Sale
Bernstein Harold

President, R&D & CMO

Officer
1,000 -34.4%
26.01
US$100,000 		1,000 -34.4% 26.01 US$100,000
2026-09-04 2026-09-03 S Sale
Dandekar Atul

CSBO

Officer
1,000 -0.1%
25.81
US$100,000 		1,000 -0.1% 25.81 US$100,000
2026-09-04 2026-09-03 S Sale
Dandekar Atul

CSBO

Officer
1,000 -9.0%
26.01
US$100,000 		1,000 -9.0% 26.01 US$100,000
2026-09-04 2026-09-02 S Sale
4.0
Courtney Phillips

GC and Corp. Secretary

Officer
1,000 -2.6%
27.12
US$100,000 		1,000 -2.6% 27.12 US$100,000
2026-09-04 2026-09-02 S Sale
4.0
Courtney Phillips

GC and Corp. Secretary

Officer
1,000 -15.8%
26.38
US$100,000 		1,000 -15.8% 26.38 US$100,000
2026-09-04 2026-09-02 S Sale
Coloma Jason V

Chief Executive Officer

Executive Director
1,000 -3.4%
27.12
US$100,000 		1,000 -3.4% 27.12 US$100,000
2026-09-04 2026-09-02 S Sale
Coloma Jason V

Chief Executive Officer

Executive Director
1,000 -19.7%
26.38
US$100,000 		1,000 -19.7% 26.38 US$100,000
2026-09-04 2026-09-02 S Sale
Bernstein Harold

President, R&D & CMO

Officer
1,000 -4.0%
27.12
US$100,000 		1,000 -4.0% 27.12 US$100,000
2026-09-04 2026-09-02 S Sale
Bernstein Harold

President, R&D & CMO

Officer
1,000 -22.4%
26.38
US$100,000 		1,000 -22.4% 26.38 US$100,000
2026-09-04 2026-09-02 S Sale
Dandekar Atul

CSBO

Officer
1,000 -1.1%
27.12
US$100,000 		1,000 -1.1% 27.12 US$100,000
2026-09-04 2026-09-02 S Sale
Dandekar Atul

CSBO

Officer
1,000 -7.2%
26.38
US$100,000 		1,000 -7.2% 26.38 US$100,000
2026-09-02 2026-09-02 PrS Proposed sale
Atul Dandekar

Officer

Officer
6,679
26.53
US$177,200 		6,679 26.53 US$177,200
2026-09-02 2026-09-02 PrS Proposed sale
Jason V Coloma

Officer

Officer
23,497
26.53
US$623,400 		23,497 26.53 US$623,400
2026-09-02 2026-09-02 PrS Proposed sale
4.0
Courtney Phillips

Officer

Officer
4,144
26.54
US$110,000 		4,144 26.54 US$110,000
2026-09-02 2026-09-02 PrS Proposed sale
Harold Bernstein

Officer

Officer
10,685
26.53
US$283,500 		10,685 26.53 US$283,500
2026-09-03 2026-09-01 PlS Planned sale
Bernstein Harold

President, R&D & CMO

Officer
16,141 -100.0%
26.36
US$425,512 		16,141 -100.0% 26.36 US$425,512
2026-09-03 2026-09-01 PlS Planned sale
Coloma Jason V

Chief Executive Officer

Executive Director
31,908 -12.5%
26.29
US$838,785 		31,908 -12.5% 26.29 US$838,785
2026-09-03 2026-09-01 PlS Planned sale
Coloma Jason V

Chief Executive Officer

Executive Director
2,593 -12.5%
26.31
US$68,214 		2,593 -12.5% 26.31 US$68,214
2026-09-01 2026-09-01 PrS Proposed sale
Coloma Jason V

Officer

Officer
34,501
26.32
US$908,066 		34,501 26.32 US$908,066
2026-08-31 2026-08-28 PlS Planned sale
Dandekar Atul

CSBO

Officer
7,500 -22.2%
27.58
US$206,824 		7,500 -22.2% 27.58 US$206,824
2026-08-14 2026-08-13 PlS Planned sale
Bernstein Harold

President, R&D & CMO

Officer
16,142 -100.0%
27.61
US$445,621 		16,142 -100.0% 27.61 US$445,621
2026-08-05 2026-08-03 PlS Planned sale
Coloma Jason V

Chief Executive Officer

Executive Director
1,604 -0.6%
27.09
US$43,445 		1,604 -0.6% 27.09 US$43,445
2026-08-05 2026-08-03 PlS Planned sale
Coloma Jason V

Chief Executive Officer

Executive Director
30,304 -10.6%
26.71
US$809,541 		30,304 -10.6% 26.71 US$809,541
2026-08-05 2026-08-03 PlS Planned sale
Coloma Jason V

Chief Executive Officer

Executive Director
154 -0.7%
27.09
US$4,172 		154 -0.7% 27.09 US$4,172
2026-08-05 2026-08-03 PlS Planned sale
Coloma Jason V

Chief Executive Officer

Executive Director
2,439 -10.5%
26.71
US$65,157 		2,439 -10.5% 26.71 US$65,157
2026-08-03 2026-08-03 PrS Proposed sale
Coloma Jason V

Officer

Officer
34,501
26.74
US$922,557 		34,501 26.74 US$922,557
2026-07-31 2026-07-29 PlS Planned sale
Dandekar Atul

CSBO

Officer
400 -1.5%
27.89
US$11,156 		400 -1.5% 27.89 US$11,156
2026-07-31 2026-07-29 PlS Planned sale
Dandekar Atul

CSBO

Officer
7,100 -21.0%
27.31
US$193,875 		7,100 -21.0% 27.31 US$193,875
2026-07-29 2026-07-29 PrS Proposed sale
ATUL DANDEKAR

Officer

Officer
22,500
27.88
US$627,300 		22,500 27.88 US$627,300
2026-07-02 2026-07-01 PlS Planned sale
Bernstein Harold

President, R&D & CMO

Officer
1,200 -100.0%
30.34
US$36,404 		1,200 -100.0% 30.34 US$36,404
2026-07-02 2026-07-01 PlS Planned sale
Bernstein Harold

President, R&D & CMO

Officer
13,409 -91.8%
29.87
US$400,460 		13,409 -91.8% 29.87 US$400,460
2026-07-02 2026-07-01 PlS Planned sale
Coloma Jason V

Chief Executive Officer

Executive Director
1,597 -0.6%
30.44
US$48,606 		1,597 -0.6% 30.44 US$48,606
2026-07-02 2026-07-01 PlS Planned sale
Coloma Jason V

Chief Executive Officer

Executive Director
30,311 -9.5%
29.95
US$907,921 		30,311 -9.5% 29.95 US$907,921
2026-07-02 2026-07-01 PlS Planned sale
Coloma Jason V

Chief Executive Officer

Executive Director
2,593 -10.0%
29.98
US$77,726 		2,593 -10.0% 29.98 US$77,726
2026-07-01 2026-07-01 PrS Proposed sale
HAROLD BERNSTEIN

Officer

Officer
46,892
29.84
US$1,399,257 		46,892 29.84 US$1,399,257
2026-07-01 2026-07-01 PrS Proposed sale
Coloma Jason V

Officer

Officer
34,501
29.98
US$1,034,254 		34,501 29.98 US$1,034,254
2026-07-01 2026-06-29 PlS Planned sale
Dandekar Atul

CSBO

Officer
7,500 -22.2%
28.02
US$210,150 		7,500 -22.2% 28.02 US$210,150
2026-06-24 2026-06-23 PlS Planned sale
Coloma Jason V

Chief Executive Officer

Executive Director
23,865 -7.0%
26.05
US$621,674 		23,865 -7.0% 26.05 US$621,674
2026-06-24 2026-06-22 PlS Planned sale
Coloma Jason V

Chief Executive Officer

Executive Director
2,040 -7.3%
26.00
US$53,040 		2,040 -7.3% 26.00 US$53,040
2026-06-24 2026-06-22 PlS Planned sale
Coloma Jason V

Chief Executive Officer

Executive Director
1,953 -0.6%
26.00
US$50,781 		1,953 -0.6% 26.00 US$50,781
2026-06-03 2026-06-01 PlS Planned sale
Bernstein Harold

President, R&D & CMO

Officer
1,600 -100.0%
26.36
US$42,172 		1,600 -100.0% 26.36 US$42,172
2026-06-03 2026-06-01 PlS Planned sale
Bernstein Harold

President, R&D & CMO

Officer
13,253 -89.2%
25.57
US$338,940 		13,253 -89.2% 25.57 US$338,940
2026-06-03 2026-06-01 PlS Planned sale
Coloma Jason V

Chief Executive Officer

Executive Director
553 -1.9%
26.24
US$14,511 		553 -1.9% 26.24 US$14,511
2026-06-03 2026-06-01 PlS Planned sale
Coloma Jason V

Chief Executive Officer

Executive Director
6,090 -1.7%
26.20
US$159,537 		6,090 -1.7% 26.20 US$159,537
2026-06-01 2026-06-01 PrS Proposed sale
Coloma Jason V

Officer

Officer
34,501
26.32
US$908,066 		34,501 26.32 US$908,066
2026-06-02 2026-05-29 PlS Planned sale
Dandekar Atul

CSBO

Officer
7,500 -23.2%
26.34
US$197,554 		7,500 -23.2% 26.34 US$197,554
2026-05-27 2026-05-26 PlS Planned sale
Coloma Jason V

Chief Executive Officer

Executive Director
25,582 -6.8%
26.02
US$665,516 		25,582 -6.8% 26.02 US$665,516
2026-05-27 2026-05-22 PlS Planned sale
Coloma Jason V

Chief Executive Officer

Executive Director
2,478 -8.0%
26.00
US$64,428 		2,478 -8.0% 26.00 US$64,428
2026-05-27 2026-05-22 PlS Planned sale
Coloma Jason V

Chief Executive Officer

Executive Director
4,504 -1.2%
26.00
US$117,104 		4,504 -1.2% 26.00 US$117,104
2026-05-18 2026-05-15 PlS Planned sale
Coloma Jason V

Chief Executive Officer

Executive Director
116 -0.4%
26.00
US$3,016 		116 -0.4% 26.00 US$3,016
2026-05-18 2026-05-15 PlS Planned sale
Coloma Jason V

Chief Executive Officer

Executive Director
1,822 -0.5%
26.00
US$47,372 		1,822 -0.5% 26.00 US$47,372
2026-05-15 2026-05-15 PrS Proposed sale
Coloma Jason V

Officer

Officer
34,502
25.95
US$895,327 		34,502 25.95 US$895,327
2026-05-18 2026-05-14 PlS Planned sale
Bernstein Harold

President, R&D & CMO

Officer
15,000 -100.0%
26.22
US$393,354 		15,000 -100.0% 26.22 US$393,354
2026-05-01 2026-04-29 PlS Planned sale
Dandekar Atul

CSBO

Officer
7,500 -41.7%
25.37
US$190,299 		7,500 -41.7% 25.37 US$190,299
2026-04-02 2026-04-01 PlS Planned sale
Bachrodt Amy

SVP, Finance

Officer
300 -2.3%
30.34
US$9,101 		300 -2.3% 30.34 US$9,101
2026-04-02 2026-04-01 PlS Planned sale
Bachrodt Amy

SVP, Finance

Officer
300 -2.3%
30.34
US$9,101 		300 -2.3% 30.34 US$9,101
2026-04-02 2026-04-01 PlS Planned sale
Bachrodt Amy

SVP, Finance

Officer
2,200 -14.2%
29.32
US$64,510 		2,200 -14.2% 29.32 US$64,510
2026-04-02 2026-04-01 PlS Planned sale
Bachrodt Amy

SVP, Finance

Officer
2,200 -14.2%
29.32
US$64,510 		2,200 -14.2% 29.32 US$64,510
2026-04-02 2026-04-01 PlS Planned sale
Bernstein Harold

President, R&D & CMO

Officer
300 -100.0%
31.07
US$9,320 		300 -100.0% 31.07 US$9,320
2026-04-02 2026-04-01 PlS Planned sale
Bernstein Harold

President, R&D & CMO

Officer
3,348 -91.8%
30.06
US$100,636 		3,348 -91.8% 30.06 US$100,636
2026-04-02 2026-04-01 PlS Planned sale
Bernstein Harold

President, R&D & CMO

Officer
11,352 -75.7%
29.24
US$331,948 		11,352 -75.7% 29.24 US$331,948
2026-04-01 2026-03-30 PlS Planned sale
Dandekar Atul

CSBO

Officer
790 -7.0%
30.02
US$23,714 		790 -7.0% 30.02 US$23,714
2026-04-01 2026-03-30 PlS Planned sale
Dandekar Atul

CSBO

Officer
6,710 -37.3%
29.26
US$196,305 		6,710 -37.3% 29.26 US$196,305
2026-03-30 2026-03-30 PrS Proposed sale
ATUL DANDEKAR

Officer

Officer
30,000
30.38
US$911,400 		30,000 30.38 US$911,400
2026-03-20 2026-03-20 PlS Planned sale
Bernstein Harold

President, R&D & CMO

Officer
5,044 -100.0%
50.02
US$252,294 		5,044 -100.0% 50.02 US$252,294
2026-03-20 2026-03-20 PlS Planned sale
Bernstein Harold

President, R&D & CMO

Officer
3,795 -42.9%
49.32
US$187,169 		3,795 -42.9% 49.32 US$187,169
2026-03-20 2026-03-20 PlS Planned sale
Bernstein Harold

President, R&D & CMO

Officer
6,161 -41.1%
48.20
US$296,977 		6,161 -41.1% 48.20 US$296,977
2026-03-12 2026-03-10 PlS Planned sale
Bernstein Harold

President, R&D & CMO

Officer
348 -100.0%
51.02
US$17,753 		348 -100.0% 51.02 US$17,753
Explore more

More insider trading research around Maze Therapeutics, Inc.

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America